BioAtla, Inc.BCABNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank87
3Y CAGR+10.2%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+10.2%/yr
Quarterly compound
Percentile
P87
Within normal range
vs 3Y Ago
1.3x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 202515.62%
Q2 2025-23.08%
Q1 202513.33%
Q4 2024-36.36%
Q3 202450.00%
Q2 20248.33%
Q1 202414.29%
Q4 202320.00%
Q3 20236.67%
Q2 2023-36.36%
Q1 202312.70%
Q4 20227.35%
Q3 202211.69%
Q2 2022-18.46%
Q1 20225.80%
Q4 2021-1.47%
Q3 202124.44%
Q2 2021-60.71%
Q1 2021-14.29%
Q4 2020-28.95%
Q3 2020-31.03%
Q2 2020-290.31%
Q1 2020-17.94%
Q4 20190.00%